Energesis Pharmaceuticals Inc.

Newton, MA

UEI
JA9AEU5KN7R1
CAGE
5T2D9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
84 Paul St, Newton, MA 02459, USA
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
DHP sbir phase II #H2-0092 W81XWH15C0090 Medical Command (Army) $998,628
Sttr phase 1 A11A-034-0222-1 W81XWH11C0517 Medical Command (Army) $848,634

Grant awards

Award Agency Obligated Awarded
In vivo proof of concept and target identification using small molecule stimulators of brown adipogenesis R44DK125193 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $4,995,700
Development of novel brown adipocyte recruiters for the treatment of obesity R43DK125193 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $295,420
Optimization and pre-clinical studies of a protein therapeutic for recruiting brown adipocytes R44DK113877 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $1,775,542
Establishing in vivo proof of concept of brown adipogenesis using approved drugs R44DK109860 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $1,781,519
Target identification of proteins and peptides capable of recruitment of brown ad R43DK101205 National Institutes of Health $276,203

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Energesis Pharmaceuticals Inc. registered in SAM.gov?

Yes. Energesis Pharmaceuticals Inc.'s SAM.gov registration is active through September 17, 2027.

What is Energesis Pharmaceuticals Inc.'s most recent federal award?

Energesis Pharmaceuticals Inc.'s most recent federal grant award is In vivo proof of concept and target identification using small molecule stimulators of brown adipogenesis (R44DK125193), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on July 1, 2020.

On GovTribe

See Energesis Pharmaceuticals Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login